The Cannabis Investing Podcast

By: Seeking Alpha
  • Summary

  • On Seeking Alpha's Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis and psychedelics industries.

    Sector experts, top analysts and C-level executives highlight industry trends, share portfolio strategies and help you think through your investing approach.

    Transcripts: seekingalpha.com/cannabisinvestingpodcast
    Copyright Seeking Alpha
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Why cannabis is still an excellent long-term investment opportunity
    Sep 23 2024
    Jesse Redmond highlights the fine line between being early and wrong and why having a long-term timeline is wise for cannabis investors (2:10). Why Florida is a massive opportunity (9:35). Green Thumb, Verano and pushing for more company transparency (17:50). Pennsylvania a state-led catalyst; solving for the current risks to getting into cannabis (26:05). Farm Bill flower, the hemp conversation, valid excitement over Ohio and Minnesota and Glass House (31:20). Top 3 ways to allocate capital for retail cannabis investors (52:00).

    Read episode transcripts

    Show Notes:
    Trump appears open to decriminalizing marijuana
    Ayr CEO David Goubert On Florida, Ohio And 'Very Balanced' Q2
    Texas Cannabis, Delta-8 And Delta-9
    Glass House's Graham Farrar On Industry Challenges And Opportunities

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show more Show less
    59 mins
  • Ayr CEO David Goubert on Florida, Ohio and 'very balanced' Q2
    Aug 28 2024
    Ayr Wellness CEO David Goubert talks 'very balanced' Q2 earnings. (1:15) Focus on state footprints: Florida legalization, Ohio's nice rollout. (6:00) Debt and dilution: progress and strategies. (8:15) Any plans to grow hemp? (21:15) Industry valuations as the market evolves and legalization develops. (23:00) How to establish a national brand and the general cannabis retail picture. (36:00)

    Read episode transcripts

    Show Notes:
    Ayr Wellness CEO David Goubert Focused On Debt And Cash
    Cannabis stocks on watch as DEA sets hearing on marijuana rescheduling
    Ayr Wellness Q2 2024 Earnings Call Transcript
    Florida MSO Trump Card

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions



    Show more Show less
    45 mins
  • Psychedelic stocks: focus on their cash
    Aug 15 2024
    Jason Najum has covered the psychedelic space for a long time and contextualizes recent news around the FDA, MDMA, PTSD and Lykos Therapeutics (1:35). Blessing in disguise for Cybin, COMPASS Pathways and MindMed (14:30)? Trial data and cash in the bank are top signifiers of success (22:35). How Atai fell behind and dropped out of the conversation (24:00). Upcoming catalysts - patience required (26:35). For psychedelic medicine, does it matter who's in the White House (29:30)?

    Read episode transcripts

    Show Notes:
    FDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks Unchanged
    MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors
    ATAI: Enormous Potential Upside But No Clarity Yet
    De-Risking Psychedelics: Compass Pathways, Cybin And Atai

    For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Show more Show less
    37 mins

What listeners say about The Cannabis Investing Podcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.